CHDE
US
AU
UK
KR
FR
DE
CA
JP
SE
NL
ES
NO
IT
BE
FI
HR
OUR MISSION
To delight our customers and patients with the highest quality products and services for the treatment of Obstructive Sleep Apnea (OSA).
SomnoMed
Share Price
Last updated: 12/10/24 11:14:41
$0
0 (0)
Today's Open
$0
Intraday High
$0
Intraday Low
$0
Volume
0
About SomnoMed
We are the global leader in oral appliances for the
treatment of sleep apnea.
INVESTOR CENTRE
ASX Announcements
Director Appointment/Resignation
03-10-2024
•
PDF
Corporate Governance Statement
30-09-2024
•
PDF
Appendix 4G
30-09-2024
•
PDF
Annual Report to shareholders
30-09-2024
•
PDF
Change of Director's Interest Notice
23-09-2024
•
PDF
Change of Director's Interest Notice
09-09-2024
•
PDF
Investor Presentation
28-08-2024
•
PDF
FY24 Preliminary Report and FY25 Guidance
28-08-2024
•
PDF
Preliminary Final Report
28-08-2024
•
PDF
Investor Presentation
28-08-2024
•
PDF
FY24 Preliminary Report and FY25 Guidance
28-08-2024
•
PDF
Preliminary Final Report
28-08-2024
•
PDF
FY24 full year results investor conference call details
21-08-2024
•
PDF
Quarterly Cashflow Report
24-07-2024
•
PDF
Quarterly Activities Report
24-07-2024
•
PDF
Quarterly Cashflow Report
24-07-2024
•
PDF
Quarterly Activities Report
24-07-2024
•
PDF
Change of Director's Interest Notice
01-07-2024
•
PDF
Change of Director's Interest Notice
01-07-2024
•
PDF
Notification regarding unquoted securities - SOM
01-07-2024
•
PDF
Notification regarding unquoted securities - SOM
28-06-2024
•
PDF
Results of Meeting
27-06-2024
•
PDF
Completion of retail component of Entitlement Offer
03-05-2024
•
PDF
Proxy Form
20-05-2024
•
PDF
Notice of Extraordinary General Meeting
20-05-2024
•
PDF
Repayment of Epsilon facility
13-05-2024
•
PDF
Quarterly Activities Report
29-04-2024
•
PDF
Quarterly Cashflow Report
29-04-2024
•
PDF
Replacement Prospectus
16-04-2024
•
PDF
Reinstatement to Quotation
10-04-2024
•
PDF
Completion of institutional component of Entitlement Offer
10-04-2024
•
PDF
Investor Presentation
09-04-2024
•
PDF
Prospectus Entitlement Offer
09-04-2024
•
PDF
Revised guidance and capital raising
09-04-2024
•
PDF
Update on voluntary suspension & FY24 earnings guidance
05-04-2024
•
PDF
Suspension from Quotation
02-04-2024
•
PDF
Trading Halt
27-03-2024
•
PDF
Investor presentation
28-02-2024
•
PDF
Solid start in 1H as core business revenues increase 13%
28-02-2024
•
PDF
Half Yearly Report and Accounts
28-02-2024
•
PDF
Results of AGM of SomnoMed 2023
24-11-2023
•
PDF
SOM AGM 2023 Chair and CEO Address Final
24-11-2023
•
PDF
SOM ASX Release Q1 FY24
30-10-2023
•
PDF
SomnoMed Wilsons Conference October 2023
30-10-2023
•
PDF
SomnoMed Proxy Form 2023
23-10-2023
•
PDF
Notice of AGM of SomnoMed 2023 - FINAL
23-10-2023
•
PDF
Notification of cessation of securities 2623146
12-10-2023
•
PDF
Final Director's Interest Notice 2623006
12-10-2023
•
PDF
SOM Director resignation HBrett
11-10-2023
•
PDF
Notice of changes of interest of substantial holder 2617836
03-10-2023
•
PDF
SOM Appendix 4C FY23 Q1-final
30-09-2023
•
PDF
SomnoMed Limited Appendix 4G FY23final
28-09-2023
•
PDF
SomnoMed Limited Corporate Governance Statement 2023-final_
28-09-2023
•
PDF
SomnoMed Limited Corporate Governance Charters 2023 final
28-09-2023
•
PDF
2023.09.28 SOM APP3Y H Brett
28-09-2023
•
PDF
2023.09.28 SOM APP3Y H Corlett
28-09-2023
•
PDF
Appendix_03YAB 28 Sept 23
28-09-2023
•
PDF
Appendix_03Ynva 28 Sept 2023
28-09-2023
•
PDF
Guy Russo - App3Y 28 Sept 2023
28-09-2023
•
PDF
Michael Gordon -App3Y 28 Sept 2023
28-09-2023
•
PDF
Notice of change of interests of substantial holder 2614941
28-09-2023
•
PDF
Application for quotation of +securities App2A 27.9.23
27-09-2023
•
PDF
Completion of Entitlement Offer 26.9.23
26-09-2023
•
PDF
2023.09.08 SOM APP3Y H Corlett
13-09-2023
•
PDF
2023.09.08 SOM APP3Y H Brett Final
13-09-2023
•
PDF
Notice of change of interests of substantial holder 2606817
12-09-2023
•
PDF
Notice of change of interests of substantial holder 2606735
12-09-2023
•
PDF
Notice of change of interests of substantial holder 2606464
11-09-2023
•
PDF
Notice of change of interests of substantial holder 2606171
11-09-2023
•
PDF
Notice of change of interest of substantial holder 2605713
11-09-2023
•
PDF
SOM - Placement Cleansing Notice 8.9.23
08-09-2023
•
PDF
SOM - dispatch of Retail Offer Booklet
07-09-2023
•
PDF
SOM - ineligible shareholder letter- Final
06-09-2023
•
PDF
SomnoMed - Retail Entitlement Offer Booklet Final-6.9.23
06-09-2023
•
PDF
Appendix 2A 7.9.23
07-09-2023
•
PDF
SOM Completion - ASX Announcement (Clean) 4.9.23
04-09-2023
•
PDF
New Issue Announcement
03-09-2023
•
PDF
SOM - FY23 Results and Capital Raising Presentation (Final)
03-09-2023
•
PDF
SomnoMed - Preliminary Accounts FY23 20230830_Final lodgement
03-09-2023
•
PDF
SomnoMed Limited - ASX Announcement of FY23 Results + ANREO final
03-09-2023
•
PDF
Entitlement Offer Cleansing Notice - Final
03-09-2023
•
PDF
ASX Release - Investor conference call and webcast details - FY23 results amended 28.8.23
28-08-2023
•
PDF
ASX Release - Investor conference call and webcast details - FY23 results amended
17-08-2023
•
PDF
ASX Release - Investor conference call and webcast details - FY23 results
17-08-2023
•
PDF
Notification of cessation of securities SOM 31.7.23
17-08-2023
•
PDF
SOM ASX Release Q4 FY23 FINAL_26072023
17-08-2023
•
PDF
SOM Appendix 4C Q4 2023_FINAL 26072023
17-08-2023
•
PDF
CFO appointment
05-07-2023
•
PDF
SOM-ASX_Release-FY23_Q3
28-04-2023
•
PDF
SomnoMed_Appendix_4C_FY2023_Q3
31-03-2023
•
PDF
Appendix_03YAB Feb 23
28-02-2023
•
PDF
SomnoMed - 4D December 2022
22-02-2023
•
PDF
SOM-Results_ASX-1H23-22.2.23
22-02-2023
•
PDF
SOM ASX Release Q2 FY23 FINAL
01-02-2023
•
PDF
SomnoMed-Appendix_4C-FY2023_Q2
01-02-2023
•
PDF
Change of Registry Address
31-10-2022
•
PDF
SomnoMed Proxy 2022
25-10-2022
•
PDF
Notice of AGM of SomnoMed 2022
25-10-2022
•
PDF
SomnoMed_Appendix_4C_FY2023_Q1_FINAL_
26-10-2022
•
PDF
Notice of change of interests of substantial holder 4.10.22
04-10-2022
•
PDF
SOM APP3Y H Corlett 30.9.22
30-09-2022
•
PDF
SOM Preliminary Accounts FY22
22-08-2022
•
PDF
ASX FY22 release info
08-08-2022
•
PDF
SomnoMed_Appendix_4C_FY2022_Q4
08-08-2022
•
PDF
SOM ASX Release Q4 FY22 Final
08-08-2022
•
PDF
Notice of change of interests of substantial holder 31.5.22
31-05-2022
•
PDF
SOM ASX Release Q3 FY22
27-04-2022
•
PDF
SomnoMed-Appendix 4C FY2022 Q3
27-04-2022
•
PDF
Appendix_03Ynva March 2022
18-03-2022
•
PDF
SOM Results Presentation 1H22
21-02-2022
•
PDF
Rest Assure Release
21-02-2022
•
PDF
SOM 1H FY22 Release
21-02-2022
•
PDF
SomnoMed - Appendix 4D and HY Financial report 31 December 2021-22.2.22
21-02-2022
•
PDF
ASX Release - Investor conference call and webcast details H1FY22 results
14-02-2022
•
PDF
ASX Release Q2 FY22
27-01-2022
•
PDF
SomnoMed Appendix_4C-FY2022_Q2
27-01-2022
•
PDF
SomnoMed announces world's first technology enabled oral appliance 31.1.22
30-01-2022
•
PDF
2024 Annual Report
SOM Investor Presentation 1H24-final
08-08-2024
•
PDF
FY24-Preliminary-Report-and-FY25-Guidance
28-08-2024
•
PDF
Preliminary-Final-Report
28-08-2024
•
PDF
Quarterly-Cashflow-Report
24-07-2024
•
PDF
Quarterly-activities-report
24-07-2024
•
PDF
Quarterly-Activities-Report
29-04-2024
•
PDF
Quarterly-Cash-flow-report
29-04-2024
•
PDF
Investor-Presentation
09-04-2024
•
PDF
2023 Annual Report
SOM AGM Presentation 2023
06-09-2023
•
PDF
SOM Investor Presentation-22.2.23
22-02-2023
•
PDF
2022 Annual Report
SOM Investor Presentation FY22
30-09-2022
•
PDF
SOM Results Presentation 1H22
30-03-2022
•
PDF
2021 Annual Report
ASX-Release-Q1-FY21-FINAL
08-09-2021
•
PDF
2020 Annual Report
2019 Annual Report
2018 Annual Report
2017 Annual Report
2016 Annual Report
2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
FY24 Full Year Financial Reports
28-08-2024
Annual General Meeting
27-11-2024
Wilsons FY24
Wilsons Equity Research Report – SOM – 26 July 2022
Retaining guidance following a patchy 3Q22 – 27 April2022
CPAP had better watch out! – 23 February 2022
Pricing in structural innovation – 25 August 2021
BUY: And suddenly, Germany – 22 August 2019
BUY: US sales growth equals margin and EPS – 25 July 2019
New BUY: Back to doing what they are world’s best at – 21 February 2019
HOLD: RSS pull-back a necessary mea culpa – 23 August 2018
BUY: Scrappy 1Q – Europe the powerhouse supporting outlook and RSS investment – 1 November 2017
BUY: US channel conflicts abating in Q4- 27 April 2017
An eye on RSS channel conflict but the core offering to prevail in US direct market – 24 February 2017
RSS taking patients in Oklahoma; good Q2 – 24 January 2017
Record Q1, SCA progress and France ratchets up reimbursement for oral appliance therapy – 19 October 2016
Organic goodness – 19 August 2016
Exciting FY17 ahead for core earnings, SCA clinic roll-out and new management – 25 July 2016
MAS Appeal – 1 June 2016
Sustained European growth underpins a solid Q2 – upgrading FY16 – 19 January 2016
SOM-20240918-initiation-Taylor-Collison
Morgans_Strong_growth_across_major_sales_engines
Steady for now but potential growth driver ahead – 28 April 2022
Bridging the feedback loop to CPAP – February 22 2022
Lying in wait – 28 October 2021
Buyers on weakness – 24 August 2021
Growth mode re-engaged – 23 February 2021
A strong run but more to come – 21 October 2020
Muddy result, clearer outlook – 21 August 2019
Pain for no gain – 27 November 2018
Coming into a seasonally strong period – 21 November 2017
A transitional year – 26 April 2017
Building for growth – 18 August 2016
Moving down the supply chain – 29 May 2016
SOM Research Note Update – 9 September 2022
MST Access – SOM Update – 27 July 22
MST Access – SOM Update – 2 May 2022
MST Access – SOM Initiation – 28 February 2022
Select Equities Stock Update -11 September 2019
Select Equities Stock Update – 20 January 2016
SHAREHOLDER
Contacts
Contact Investor Relations
Have a question for SomnoMed? Send us an email at the address below and our team will be in contact shortly.
Shareholder Services
Shareholders can access information such as holding balance, change of address, and annual report preferences by contacting Boardroom Pty Ltd using the form below:
